Comments

Novavax Stock Price, Quotes and Forecasts

Q: What sector and industry does Novavax (NVAX) operate in?

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NVAXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$7.60

0.000.00%

Pre-Market: 4:01 AM EDT

Novavax (NVAX) Forecast

News Earnings Novavax (NVAX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Novavax Stock Price, Quotes and Forecasts | NASDAQ:NVAX | Benzinga

Explore Novavax stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NVAX.

Open	-
Close	-
Volume / Avg.	396.00 / 4.29M
Day Range	- - -
52 Wk Range	3.81 - 23.86
Market Cap	$1.22B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	30.38%
Days to Cover	6.39

Recent News

Nvidia, Tesla Lead Tech Stock Rebound: What's Driving Markets Friday?

Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQ:NVDA) up 1.37% and Tesla, Inc. (NASDAQ:TSLA)

Erica Kollmann

Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value

Novavax reported Q4 sales of $88.31 million, beating estimates despite a decline. The company shifts focus to partnerships and expects up to $350 million in 2025 revenue.

Vandana Singh

Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch (CORRECTED)

A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye."

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	396.00 / 4.29M
Day Range	- - -
52 Wk Range	3.81 - 23.86
Market Cap	$1.22B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	30.38%
Days to Cover	6.39

About Novavax, Inc.

Sector

Health Care

Industry

Biotechnology

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical sta...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Novavax (NVAX) stock?

You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.

View our list of the best stock brokerages

Who are Novavax (NVAX) competitors?

Other companies in Novavax’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Ascentage Pharma Group (NASDAQ:AAPG) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for Novavax (NVAX) stock?

Novavax has a consensus price target of $48.13.

What is the current price for Novavax (NVAX)?

The stock price for Novavax (NASDAQ: NVAX) is $7.6 last updated March 24, 2025 at 4:01 AM EDT.

Does Novavax (NVAX) pay a dividend?

There are no upcoming dividends for Novavax.

When is Novavax (NASDAQ:NVAX) reporting earnings?

Novavax’s Q1 earnings are confirmed for Friday, May 9, 2025.

Is Novavax (NVAX) going to split?

There is no upcoming split for Novavax.

What sector and industry does Novavax (NVAX) operate in?

Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.